Hee-Jung Wang

2.0k total citations
80 papers, 1.4k citations indexed

About

Hee-Jung Wang is a scholar working on Hepatology, Surgery and Molecular Biology. According to data from OpenAlex, Hee-Jung Wang has authored 80 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hepatology, 34 papers in Surgery and 21 papers in Molecular Biology. Recurrent topics in Hee-Jung Wang's work include Hepatocellular Carcinoma Treatment and Prognosis (26 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers) and Organ Transplantation Techniques and Outcomes (13 papers). Hee-Jung Wang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (26 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers) and Organ Transplantation Techniques and Outcomes (13 papers). Hee-Jung Wang collaborates with scholars based in South Korea, United States and China. Hee-Jung Wang's co-authors include Bong‐Wan Kim, Jae Youn Cheong, YongKeun Park, Jung‐Hee Kwon, Namgyu Lee, Gyesoon Yoon, Young‐Kyoung Lee, Myung-Wook Kim, Kwan Yong Choi and Weiguang Xu and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hee-Jung Wang

80 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hee-Jung Wang South Korea 22 511 433 373 352 333 80 1.4k
Kazuhiro Koikawa Japan 10 238 0.5× 169 0.4× 505 1.4× 141 0.4× 207 0.6× 15 1.2k
Zhenru Wu China 22 820 1.6× 268 0.6× 249 0.7× 547 1.6× 176 0.5× 94 1.7k
Stefano Realdon Italy 21 312 0.6× 255 0.6× 404 1.1× 205 0.6× 309 0.9× 75 1.4k
Matteo Montani Switzerland 18 122 0.2× 264 0.6× 238 0.6× 116 0.3× 323 1.0× 44 840
Yanling Feng China 19 324 0.6× 89 0.2× 173 0.5× 170 0.5× 216 0.6× 70 1.1k
Alessandro Cappellani Italy 23 477 0.9× 244 0.6× 939 2.5× 398 1.1× 322 1.0× 95 2.1k
Noritoshi Kobayashi Japan 28 314 0.6× 392 0.9× 1.1k 2.9× 164 0.5× 1.0k 3.1× 159 2.8k
Jin Mo Yang South Korea 23 203 0.4× 922 2.1× 384 1.0× 127 0.4× 757 2.3× 102 1.8k
Da Xu China 24 839 1.6× 297 0.7× 279 0.7× 592 1.7× 181 0.5× 71 2.1k
Charlotte Costentin France 25 233 0.5× 1.1k 2.5× 325 0.9× 228 0.6× 724 2.2× 71 1.9k

Countries citing papers authored by Hee-Jung Wang

Since Specialization
Citations

This map shows the geographic impact of Hee-Jung Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hee-Jung Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hee-Jung Wang more than expected).

Fields of papers citing papers by Hee-Jung Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hee-Jung Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hee-Jung Wang. The network helps show where Hee-Jung Wang may publish in the future.

Co-authorship network of co-authors of Hee-Jung Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Hee-Jung Wang. A scholar is included among the top collaborators of Hee-Jung Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hee-Jung Wang. Hee-Jung Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoon, Sarah, Ji Hye Choi, Masaud Shah, et al.. (2021). USO1 isoforms differentially promote liver cancer progression by dysregulating the ER–Golgi network. Carcinogenesis. 42(9). 1208–1220. 3 indexed citations
2.
Kim, In‐Gyu, et al.. (2020). 18F-fluorodeoxyglucose PET/CT as an independent predictor for patients with hepatocellular carcinoma combined with major portal vein tumor thrombus. Annals of Surgical Treatment and Research. 99(1). 8–8. 1 indexed citations
3.
Lee, Young‐Kyoung, So Mee Kwon, Seongki Min, et al.. (2020). Mitochondrial Respiratory Defect Enhances Hepatoma Cell Invasiveness via STAT3/NFE2L1/STX12 Axis. Cancers. 12(9). 2632–2632. 20 indexed citations
4.
Wang, Hee-Jung, et al.. (2019). Can we delineate preoperatively the right and ventral margins of caudate lobe of the liver?. Annals of Surgical Treatment and Research. 97(3). 124–124. 5 indexed citations
5.
6.
7.
Lee, Jei Hee, Bohyun Kim, Hye Jin Kim, Bong‐Wan Kim, & Hee-Jung Wang. (2018). High spatial resolution navigated 3D T1-weighted hepatobiliary MR cholangiography using Gd-EOB-DTPA for evaluation of biliary anatomy in living liver donors. Abdominal Radiology. 43(7). 1703–1712. 8 indexed citations
8.
Yoon, Sarah, Eun‐Ju Lee, Ji Hye Choi, et al.. (2018). Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer. Oncogene. 37(32). 4443–4454. 10 indexed citations
9.
Park, YongKeun, et al.. (2017). Conditional Survival Analysis Demonstrates that Recurrence Risk of Surgically Treated Hepatocellular Carcinoma Evolves with Time. Journal of Gastrointestinal Surgery. 21(8). 1237–1244. 9 indexed citations
10.
Kim, Bong‐Wan, et al.. (2016). Risk factor for ischemic-type biliary lesion after ABO-incompatible living donor liver transplantation. World Journal of Gastroenterology. 22(30). 6925–6925. 9 indexed citations
11.
12.
Kwon, Jung‐Hee, Keun Soo Ahn, Young Ho Moon, et al.. (2015). AROS Is a Significant Biomarker for Tumor Aggressiveness in Non-cirrhotic Hepatocellular Carcinoma. Journal of Korean Medical Science. 30(9). 1253–1253. 7 indexed citations
13.
Kim, Bong‐Wan, Hee-Jung Wang, Hyun Young Lee, et al.. (2015). Quantitative Assessment of the Portal Pressure for the Liver Surgery Using Serological Tests. Annals of Surgery. 264(2). 330–338. 11 indexed citations
14.
15.
Kim, Bong‐Wan, Weiguang Xu, Hee-Jung Wang, et al.. (2011). Volumetry-based selection of right posterior sector grafts for adult living donor liver transplantation. Liver Transplantation. 17(9). 1046–1058. 20 indexed citations
16.
Kim, Jongmin, Jun Ho Park, Sun Young Park, et al.. (2010). Epithelial–mesenchymal transition gene signature to predict clinical outcome of hepatocellular carcinoma. Cancer Science. 101(6). 1521–1528. 39 indexed citations
17.
Cheong, Jae Youn, Sung Won Cho, Marie Yeo, et al.. (2006). Genetic Polymorphism of Interferon-γ, Interferon-γ Receptor, and Interferon Regulatory Factor-1 Genes in Patients with Hepatitis B Virus Infection. Biochemical Genetics. 44(5-6). 246–255. 31 indexed citations
18.
Wang, Hee-Jung. (2004). Cancer Registry for Primary Liver Cancer. Korean Journal of Hepato-Biliary-Pancreatic Surgery. 8(4). 207–216. 2 indexed citations
19.
Heo, Jeong, et al.. (2004). 간문맥 혈전이 동반된 진행성 간세포암에서 간동맥내 항암제 주입요법. The Korean Journal of Internal Medicine. 67(1). 40–48. 1 indexed citations
20.
Won, Je Hwan, Jong Doo Lee, Hee-Jung Wang, et al.. (2002). Self-expandable covered metallic esophageal stent impregnated with beta-emitting radionuclide: an experimental study in canine esophagus. International Journal of Radiation Oncology*Biology*Physics. 53(4). 1005–1013. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuhiro Koikawa Breakdown of academic impact, for papers by Zhenru Wu Breakdown of academic impact, for papers by Stefano Realdon Breakdown of academic impact, for papers by Matteo Montani Breakdown of academic impact, for papers by Yanling Feng Breakdown of academic impact, for papers by Alessandro Cappellani Breakdown of academic impact, for papers by Noritoshi Kobayashi Breakdown of academic impact, for papers by Jin Mo Yang Breakdown of academic impact, for papers by Da Xu Breakdown of academic impact, for papers by Charlotte Costentin
Rankless by CCL
2026